Company Encyclopedia
View More
name
Novanta
NOVT.US
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications.
686.01 B
NOVT.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Electronic Equipment and InstrumentsIndustry
Industry Ranking37/104
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE6.84%C
    • Profit Margin5.50%C
    • Gross Margin44.76%B
  • Growth ScoreC
    • Revenue YoY4.07%C
    • Net Profit YoY-12.16%D
    • Total Assets YoY6.13%B
    • Net Assets YoY7.99%B
  • Cash ScoreB
    • Cash Flow Margin1818.01%B
    • OCF YoY4.07%C
  • Operating ScoreB
    • Turnover0.66B
  • Debt ScoreC
    • Gearing Ratio46.77%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Novanta (NASDAQ:NOVT) Stock Price Down 6.1% - Should You Sell?

    Novanta Inc.'s stock price fell 6.1% during mid-day trading, with analysts adjusting price targets and ratings. The stock's consensus rating is "Reduce," with a target price of $133.00. Novanta reported better-than-expected quarterly earnings and announced a $200 million share buyback plan. Institutional investors hold 98.35% of the stock. The company operates in healthcare and advanced industrial sectors through its Photonics, Vision, and Precision Motion segments.

    Market Beat·
    US
    NOVT
    +2.75%
    Market Beat·
    US
    NOVT
    +2.75%

    Morning Trend | Novanta preferred shares experience extreme volume reduction, is a dividend event about to happen?

    Novanta Preferred Shares NOVTU (NOVTU.US) is experiencing extremely low volume and horizontal trading, with sporadic transactions triggering high-risk dividend speculation in the market. Community discussions about "whether a significant movement is brewing" have become extremely heated. Currently, the buy and sell orders are very thin, and recent fluctuations in U.S. Treasury yields have made some high-dividend targets' chips extremely scarce. Under the market's FOMO mentality, there could be a continuous surge in volume or significant fluctuations at any moment. The technical indicators are all aligned, with moving averages and indicators lacking direction. Many veteran players remind that "extreme low-volume phases often lead to more intense movements." On-site funds are mostly adopting a very conservative strategy, but if a major player suddenly takes action, it could be a precursor to an abnormal outbreak. The key to current operations is to maintain a high level of vigilance, capturing any unusual flashes in the market. If there is a rapid increase in trading volume during the session, immediate reaction is necessary. The risks of gaps and price drops should not be taken lightly either. As long as there is a wave of dividend-driven momentum or concentrated buying from major players, the short-term main upward wave of the dividend market could suddenly launch

    Technical Forecast·
    US
    NOVT
    +2.75%
    Technical Forecast·
    US
    NOVT
    +2.75%

    Morning Trend | Novanta NOVTU main force sweeps goods, short-term opportunities in bond-themed investments emerge?

    Novanta Pref Shares NOVTU 6.5 11/01/2028 (NOVTU.US) saw multiple instances of major buying actions in yesterday's market, sparking community discussions on "Is the short-term opportunity about to start with the rotation towards bond-like assets?" As a high-quality convertible bond with a bond-like nature, the overall trading volume in this sector has recently increased, and the flow of funds has noticeably accelerated. It is expected that if the relevant rotation funds continue to increase today at the market open, the short-term speculative space will be opened up, with a clear advantage for strategies that involve buying on dips as prices stabilize. Key attention should be paid to whether market risk appetite improves and how much capital is being transferred; if the trading volume is sufficient to break through the densely traded area in the early session, it could easily lead to a small climax during the day. During the session, track the intraday turnover rate and observe whether there are continuous signals of large orders sweeping the market. The operational suggestion is to flexibly control positions, set stop-losses in line with the overall market environment, and prevent excessive pullbacks in convertible bonds or sudden drops in liquidity that could lead to price fluctuations. Quick players can seize the opportunity during the game between both sides, adhering to the principle of "getting in when contradictions intensify and exiting when good news is realized," while more conservative investors should focus on intraday dips and rotational arbitrage

    Technical Forecast·
    US
    NOVT
    +2.75%
    Technical Forecast·
    US
    NOVT
    +2.75%

    Novanta Lowers 2025 Adjusted EPS Guidance After Equity Issuance

    Novanta Inc. has revised its financial guidance for Q4 and full year 2025 due to a recent equity issuance. Adjusted diluted EPS for Q4 is now expected to be $0.84-$0.91, down from $0.87-$0.93. Full year 2025 adjusted diluted EPS is revised to $3.21-$3.28, down from $3.24-$3.30. GAAP revenue and adjusted EBITDA guidance remain unchanged.

    Reuters·
    US
    NOVT
    +2.75%
    Reuters·
    US
    NOVT
    +2.75%

    Novanta Sells Equity Units to Strengthen Balance Sheet

    Novanta (NOVT) has announced the sale of 11 million tangible equity units at $50 each, with an over-allotment option fully exercised, to strengthen its balance sheet and fund various corporate purposes. The offering, which includes prepaid stock purchase contracts and senior amortizing notes, is expected to enhance working capital and support potential acquisitions. Additionally, Novanta amended its credit agreement to increase leverage ratio limits. Analysts currently rate NOVT stock as a Hold with a price target of $115.00, reflecting strong financial performance but short-term risks due to high valuation and bearish technical indicators.

    Tip Ranks·
    US
    NOVT
    +2.75%
    Tip Ranks·
    US
    NOVT
    +2.75%
    © 2025 Longbridge｜Disclaimer